You are currently browsing the archives for 19 February 2016.
Displaying 1 - 3 of 3 entries.

Conducted then the baton Thelin after her $ 195.

Pfizer Inc. Conducted then the baton Thelin after her $ 195,000 buyout of Encysive in 2008. The impressive data led investment bank Jeffries International in a research note to say macitentan macitentan paradigm shift in the paradigm shift in the the treatment PAH market.

Stumble over PAH; therapies prove difficultAlthough PAH is a disease that is considered rare, with around 1,000 new cases diagnosed each year in the U.S., is the global PAH market expanded by the increasing number from treatment options for patients. Groundbreaking is Actelion Pharmaceutical Blockbuster endothelin receptor antagonist Tracleer . The product is, however, compared to the competition, which is why the company has high hopes for macitentan, his ERA is dual. The product hit the primary endpoint in a pivotal trial PAH phase III trial recently. The company plans to file for approval worldwide in the fourth quarter. .. Biologics, Inc.

To test such as health.

Will be held this year from October 15 to 18 at the PAC Sydney Hilton Hotel under the overall theme of security of your practice Advantage treatments for ed .

The National President of the PSA, Warwick Plunkett, said Butler and enthusiasm for the agreement to open the congress was significant. – During the year, three key reports have already had published, and will continue to make a huge impact on health and has it delivered as in Australia, Mr Plunkett said. – It is a great privilege for PAC09 Mr. Butler and I are open to believe that this reflects the value that the government places on the pharmacy profession as a focal point of health care in this country.

Carotid artery stenting with the study procedure.

Treat CREST, a randomized clinical trial comparing carotid endarterectomy in a joint operation a narrowing of the carotid artery, carotid artery stenting with the study procedure. During stent, a catheter is used to expand a stent in the carotid artery, where the stent to expand and contract to the blocked area and capture any dislodged plaque deliver. In the study of 2,502 participants, the results showed nine years,it people at risk for stroke may be equally developed by a medical procedure to prevent future strokes. Michael DeBakey performed the first carotid endarterectomy in 1953 at The Methodist Hospital. 55 years later 55 years later, DeBakey ‘s legacy continues He helped us set the standard of how we treat this population of patients, and now we have another viable treatment option, ‘said Dr.

In CREST, approximately half of the patients had recent symptoms of carotid artery disease, such as a mild stroke or a transient ischemic attack, a high risk for future stroke. The other half had no symptoms, but proved to the carotid artery narrowing have a. From a variety of tests assessing carotid narrowing and plaque Such patients, called asymptomatic, are at much lower risk of stroke than those with symptoms.